Treprostinil
These highlights do not include all the information needed to use TREPROSTINIL INJECTION safely and effectively. See full prescribing information for TREPROSTINIL INJECTION. TREPROSTINIL Injection, for subcutaneous or intravenous use Initial U.S. Approval: May 2002
4b2ce4aa-4302-49db-9456-c8cf0e034968
HUMAN PRESCRIPTION DRUG LABEL
May 1, 2022
Teva Parenteral Medicines, Inc.
DUNS: 794362533
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Treprostinil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Treprostinil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Treprostinil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Treprostinil
Product Details
FDA regulatory identification and product classification information